A Phase II Trial of the Oral mTOR Inhibitor Everolimus (RAD001) in Relapsed or Refractory Waldenstrom's Macroglobulinemia

被引：0
作者：
Ghobrial, Irene M.
Gertz, Morie A.
LaPlant, Betsy
Camoriano, John [3 ]
Hayman, Suzanne R.
Lacy, Martha Q.
Chuma, Stacey
Sheehy, Patricia [1 ]
Harris, Brianna
Leduc, Renee
Rourke, Meghan
Ansell, Stephen M. [2 ]
DeAngelo, Daniel J. [1 ]
Dispenzieri, Angela
Bergsagel, Leif [3 ]
Reeder, Craig B. [3 ]
Anderson, Kenneth C.
Richardson, Paul
Treon, Steven
Witzig, Thomas E. [2 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Mayo Clin, Coll Med, Rochester, MN USA
[3] Mayo Clin, Scottsdale, AZ USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：244 / 244
页数：1
相关论文
共 50 条
[41]   Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma [J].
Tobinai, Kensei ;
Ogura, Michinori ;
Maruyama, Dai ;
Uchida, Toshiki ;
Uike, Naokuni ;
Choi, Ilseung ;
Ishizawa, Kenichi ;
Itoh, Kuniaki ;
Ando, Kiyoshi ;
Taniwaki, Masafumi ;
Shimada, Naomi ;
Kobayashi, Ken .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 92 (04) :563-570
[42]   Role of the Novel mTOR Inhibitor RAD001 (Everolimus) in Anaplastic Thyroid Cancer [J].
Papewalis, C. ;
Wuttke, M. ;
Schinner, S. ;
Willenberg, H. S. ;
Baran, A. M. ;
Scherbaum, W. A. ;
Schott, M. .
HORMONE AND METABOLIC RESEARCH, 2009, 41 (10) :752-756
[43]   Everolimus (RAD001): an mTOR inhibitor for the treatment of metastatic renal cell carcinoma [J].
Oudard, Stephane ;
Medioni, Jacques ;
Aylllon, Jorge ;
Barrascourt, Eduardo ;
Elaidi, Reza-Thierry ;
Balcaceres, Jose ;
Scotte, Florian .
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) :705-717
[44]   Phase II Trial of Weekly Bortezomib in Combination with Rituximab in Relapsed or Relapsed/Refractory Waldenstrom's Macroglobulinemia. [J].
Ghobrial, Irene M. ;
Hong, Fangxin ;
Padmanabhan, Swaminathan ;
Badros, Ashraf Z. ;
Rourke, Meghan ;
Leduc, Renee ;
Chuma, Stacey ;
Kunsman, Janet ;
Warren, Diane ;
Harris, Brianna ;
Sam, Amy ;
Anderson, Kenneth C. ;
Richardson, Paul ;
Treon, Steven ;
Weller, Edie ;
Matous, Jeffrey .
BLOOD, 2009, 114 (22) :1067-1067
[45]   Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenstrom Macroglobulinemia [J].
Ghobrial, Irene M. ;
Hong, Fangxin ;
Padmanabhan, Swaminathan ;
Badros, Ashraf ;
Rourke, Meghan ;
Leduc, Renee ;
Chuma, Stacey ;
Kunsman, Janet ;
Warren, Diane ;
Harris, Brianna ;
Sam, Amy ;
Anderson, Kenneth C. ;
Richardson, Paul G. ;
Treon, Steven P. ;
Weller, Edie ;
Matous, Jeffrey .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (08) :1422-1428
[46]   A phase I/II study of the oral mTOR inhibitor RAD001 in patients with advanced hematologic malignancies. [J].
Yee, KWL ;
Wierda, W ;
O'Brien, S ;
Thomas, D ;
Kurzrock, R ;
Fayad, LE ;
Hagemeister, FB ;
Cortes, J ;
Prestifilippo, K ;
Szatrowski, TP ;
Kantarjian, HM ;
Giles, FJ .
BLOOD, 2004, 104 (11) :287B-287B
[47]   A multicenter phase II trial (SAKK 36/06) of single-agent everolimus (RAD001) in patients with relapsed or refractory mantle cell lymphoma [J].
Renner, Christoph ;
Zinzani, Pier Luigi ;
Gressin, Remy ;
Klingbiel, Dirk ;
Dietrich, Pierre-Yves ;
Hitz, Felicitas ;
Bargetzi, Mario ;
Mingrone, Walter ;
Martinelli, Giovanni ;
Trojan, Andreas ;
Bouabdallah, Krimo ;
Lohri, Andreas ;
Gyan, Emmanuel ;
Biaggi, Christine ;
Cogliatti, Sergio ;
Bertoni, Francesco ;
Ghielmini, Michele ;
Brauchli, Peter ;
Ketterer, Nicolas .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (07) :1085-1091
[48]   PHASE II STUDY OF MTOR-INHIBITOR RAD001 AND ERLOTINIB FOR ADVANCED, GEMCITABINE-REFRACTORY PANCREATIC CANCER [J].
Javle, M. ;
Reddy, S. ;
Varadhachary, G. ;
Kaseb, A. ;
Fogelman, D. ;
Wolff, R. ;
Abbruzzese, J. .
PANCREAS, 2008, 37 (04) :476-476
[49]   Phase II study of MTOR-inhibitor RAD001 and erlotinib for advanced, gemcitabine-refractory pancreatic cancer [J].
Javle, M. ;
Fogelman, D. ;
Kaseb, A. ;
Varadhachary, G. ;
Wolff, R. ;
Abbruzzese, J. .
EJC SUPPLEMENTS, 2008, 6 (12) :104-104
[50]   The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer:: Results of a phase I study with pharmacokinetics [J].
Awada, Ahmad ;
Cardoso, Fatima ;
Fontaine, Christel ;
Dirix, Luc ;
De Greve, Jacques ;
Sotiriou, Christos ;
Steinseifer, Jutta ;
Wouters, Carine ;
Tanaka, Chiaki ;
Zoellner, Ulrike ;
Tang, Pui ;
Piccart, Martine .
EUROPEAN JOURNAL OF CANCER, 2008, 44 (01) :84-91
12345